The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Inflammatory Breast Cancer Research Foundation
321 High School Rd, NE Ste. D3, PMB 149
Brainbridge Island, WA 98110
The Inflammatory Breast Cancer Research Foundation (IBCRF) assists scientists and researchers in their quest to determine the definitive cause of inflammatory breast cancer (IBC) and to develop treatments and, ultimately, a cure. The organization's goals are to ignite interest in the study of IBC at every level; to increase awareness of IBC among primary care physicians, nursing professionals, and others to minimize the time from presentation to diagnosis; to increase public awareness to encourage woman to seek medical attention for common IBC symptoms soon after they appear; and to empower patients, caregivers, families and friends to pursue meaningful paths in support of diagnosis and treatment of IBC.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.